Adding Tirzepatide to Arthritis Therapy Delivers Superior Relief
Combining tirzepatide with standard biologic treatment dramatically improves joint pain, skin symptoms, and physical function in psoriatic arthritis.
Read AnalysisStopping Ozempic or Mounjaro? Study Projects Rapid Weight Regain
New research reveals how quickly patients regain weight after stopping popular GLP-1 medications like Wegovy and Zepbound.
Read AnalysisHow Semaglutide Cuts Calories Even When Hunger Returns
A new 60-week study reveals that semaglutide helps people eat less long-term, even after its subjective appetite-suppressing effects begin to fade.
Read AnalysisOral Semaglutide Slashes Liver Fat and Body Weight
A new clinical trial shows oral semaglutide significantly reduces body fat and improves liver health in people without diabetes.
Read AnalysisPopular GLP-1 Medications Linked to Higher Hair Loss Risk
A new study reveals a significant link between popular GLP-1 receptor agonists and an increased risk of temporary hair shedding.
Read AnalysisOral Semaglutide Shows Promise in Reducing Heavy Drinking
A new clinical trial suggests the blockbuster drug semaglutide could help people struggling with alcohol use disorder cut back on heavy drinking.
Read AnalysisDIY Semaglutide: The Dangerous Risks of Grey Market Peptides
A new study reveals that untrained adults attempting to prepare and inject unprescribed, grey-market semaglutide make critical errors over half the time.
Read AnalysisNovel Dual-Action Weekly Injection Successfully Redefines Obesity Treatment
A new phase 3 clinical trial reveals that survodutide, a weekly dual-agonist injection, helps adults achieve significant weight reduction.
Read AnalysisDual-Drug Therapy Outperforms Semaglutide Alone for Weight Loss
A combination of cagrilintide and semaglutide helped patients lose significantly more weight than semaglutide alone in a new clinical trial.
Read Analysis